West Pharmaceutical
721 hedge funds and large institutions have $20.2B invested in West Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 291 increasing their positions, 267 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
721
Holders Change
-49
Holders Change %
-6.36%
% of All Funds
10.43%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
60
Increased
291
Reduced
267
Closed
101
Calls
$92.1M
Puts
$152M
Net Calls
-$60M
Net Calls Change
-$105M
Top Buyers
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
+$194M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$172M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$159M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$119M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$112M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$130M |
| 2 |
Millennium Management
New York
|
-$130M |
| 3 |
BlackRock
New York
|
-$90.6M |
| 4 |
A
AustralianSuper
Melbourne,
Australia
|
-$90M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$84.8M |
